Welcome to LookChem.com Sign In|Join Free
  • or
5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one is a thiazolyl morpholine derivative characterized by its potent and selective inhibition of phosphoinositide 3-kinase. 5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one is significant in the field of pharmaceuticals and biochemistry due to its ability to modulate key cellular processes.

15091-04-0

Post Buying Request

15091-04-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15091-04-0 Usage

Uses

Used in Pharmaceutical Industry:
5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one is used as a potent and selective inhibitor for phosphoinositide 3-kinase. Its application is crucial in the development of therapeutic strategies targeting various diseases, particularly those involving the dysregulation of cellular signaling pathways.
Used in Cancer Research:
In cancer research, 5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one serves as a valuable tool for studying the role of phosphoinositide 3-kinase in tumor growth and progression. By inhibiting this enzyme, researchers can gain insights into the underlying mechanisms of cancer and identify potential therapeutic targets.
Used in Drug Development:
5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one is utilized in the development of novel drugs aimed at treating conditions related to the overactivation of phosphoinositide 3-kinase. Its selective inhibition properties make it a promising candidate for the creation of targeted therapies with minimal side effects.
Used in Biochemical Research:
In the field of biochemistry, 5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one is employed as a research compound to investigate the structure and function of phosphoinositide 3-kinase. This helps in understanding the enzyme's role in cellular processes and its potential as a therapeutic target.
Overall, 5,5-DiMethyl-2-(Morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one is a versatile compound with significant applications in various industries, particularly in pharmaceuticals, cancer research, drug development, and biochemistry. Its potent and selective inhibition of phosphoinositide 3-kinase makes it a valuable asset in the pursuit of novel therapeutic strategies and a deeper understanding of cellular processes.

Check Digit Verification of cas no

The CAS Registry Mumber 15091-04-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,0,9 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 15091-04:
(7*1)+(6*5)+(5*0)+(4*9)+(3*1)+(2*0)+(1*4)=80
80 % 10 = 0
So 15091-04-0 is a valid CAS Registry Number.

15091-04-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(morpholin-4-yl)-5,5-dimethyl-4,5,6,7-tetrahydrobenzothiazol-7-one

1.2 Other means of identification

Product number -
Other names 5,6-Dihydro-5,5-dimethyl-2-(4-morpholinyl)-7(4H)-benzothiazolone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15091-04-0 SDS

15091-04-0Downstream Products

15091-04-0Relevant academic research and scientific papers

FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS

-

Page/Page column 99, (2008/06/13)

A series of 5,6-dihydro-l,3-benzothiazol-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PD kinase enzymes, are accordingly of b.enefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

New derivatives of 4,5,6,7-tetrahydrobenzothiazol-7-one and 5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-8-one

Stepanov,Ivanov,Ivanova

, p. 784 - 787 (2007/10/03)

Reactions of 2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-8-ones and 2-amino-4,5,6,7-tetrahydrobenzothiazol-7-ones with butyl nitrite and copper(I) chloride yield 2-chloro derivatives which readily react with various amines to form substitution products.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 15091-04-0